Nuveen’s MediciNova MNOV Stock Holding History

Nuveen’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-184,474	Closed	-$931K	–	3471
2021 Q1	$931K	Sell	184,474 -4,564	-2%	-$26.6K	﹤0.01%	2909
2020 Q4	$995K	Sell	189,038 -7,602	-4%	-$43.6K	﹤0.01%	2812
2020 Q3	$1.03M	Buy	196,640 +12,613	+7%	+$72.7K	﹤0.01%	2674
2020 Q2	$998K	Buy	184,027 +43,002	+30%	+$228K	﹤0.01%	2624
2020 Q1	$525K	Sell	141,025 -36	-0%	-$187	﹤0.01%	2753
2019 Q4	$950K	Hold	141,061	–	–	﹤0.01%	2703
2019 Q3	$1.12M	Sell	141,061 -8,580	-6%	-$76.5K	﹤0.01%	2651
2019 Q2	$1.44M	Buy	+149,641	New	+$1.58M	﹤0.01%	2589
2016 Q1	–	Sell	-14,692	Closed	-$52	–	1460
2015 Q4	$52	Hold	14,692	–	–	﹤0.01%	1482
2015 Q3	$41	Buy	+14,692	New	+$50.2K	﹤0.01%	1520

Other funds holding MNOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nuveen's MNOV Position: Q2 2021 in Review

Nuveen sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 184,474 shares — an estimated $931K sold.

Nuveen first reported a position in MNOV in Q3 2015 and held it in 10 quarters. The position peaked at $1.44M in Q2 2019. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

Nuveen reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
Nuveen sold 184,474 MediciNova shares in Q2 2021, an estimated $931K.
Nuveen first reported a position in MediciNova in Q3 2015 and held it in 10 quarters.
Nuveen's MediciNova position peaked at $1.44M in Q2 2019.
55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.